Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 14Unknown 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Classical hematology 5Breast 3Gynecologic 2

Conditions

Ovarian Neoplasms 406Uterine Cervical Neoplasms 400Endometrial Neoplasms 197Carcinoma, Ovarian Epithelial 100Breast Neoplasms 72Fallopian Tube Neoplasms 71Uterine Cervical Dysplasia 68Neoplasms 51Colorectal Neoplasms 42Pancreatic Neoplasms 40Stomach Neoplasms 39Peritoneal Neoplasms 32Papillomavirus Infections 32Recurrence 31Uterine Neoplasms 29Vulvar Neoplasms 27Prostatic Neoplasms 26Lung Neoplasms 24Esophageal Neoplasms 23Urinary Bladder Neoplasms 22Melanoma 20Colonic Neoplasms 20Head and Neck Neoplasms 19Gynecologic Cancer 19Endometrial Hyperplasia 18Neoplasm Metastasis 17Carcinoma, Non-Small-Cell Lung 17Squamous Intraepithelial Lesions 16Sarcoma 16Ovarian Cysts 15

Interventions

Trabectedin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Fanconi Anemia, Complementation Group D1 × Gynecologic × Clear all
NCT01772979 2013-01-21

MITO15

Catholic University of the Sacred Heart

Phase 2 Unknown
100 enrolled
Classical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

NCT00155896 2005-09-12

Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer

National Taiwan University Hospital

Unknown
100 enrolled
Classical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡